Content by Affymetrix

Next-generation sequencing is leading the way in providing a cost-effective and scalable approach to detect oncology driver mutations in solid tumor samples.

Cancer is a global healthcare challenge; the healthcare industry is witnessing rapid new developments, improved point-of-care diagnostics, cost-effective treatment modalities and personalized medicine, which not only offer efficient early diagnosis but also treat cancer conditions in order to reduce the healthcare cost and disease burden